“…The most convincingly demonstrated cases of SEF are those with the typical histology, a fibroblastic ultrastructure (rER and collagen secretion granules [3]) and an immunophenotype also of fibroblastic markers only (vimentin). However, any group of tumors can show phenotypic heterogeneity and a variety of essentially nonfibroblastic markers have been reported in SEF: EMA, S-100 protein, NSE, and cytokeratin [1,2,4,5,7,8,11,12,14,15,18,21,24,25]. Therefore, the immunostaining in our case for not only vimentin but also EMA, S-100, CD34, CD99, and NSE is consistent with the literature [1,8] and indicative of a complex and divergent phenotype.…”